Module 3 2019

Intended Learning Outcomes

• A thorough understanding of knowledge of stability data requirements for registration of pharmaceuticals in the EU

• A thorough appreciation of the complexity of stability studies

• Demonstrate an understanding of causes of drug instability in order to critically evaluate stability data

The Organisation for Professionals in Regulatory Affairs